Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W Geisbert

Showing results (251-260 of 279) with videos related to

Pageof 28
Sort By:
Journal of Medicinal Chemistry|January 6, 2026
Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of HenipavirusesIrina N Gaisina, Malaika D Argade, Ryan Bott, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2016
Monoclonal antibody therapy for Junin virus infectionLarry Zeitlin, Joan B Geisbert, Daniel J Deer, et al.
Vaccines|October 27, 2022
Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical TrialsChristopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
The Journal of Infectious Diseases|July 20, 2023
Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal AntibodyDafna Abelson, Jennifer Barajas, Lauren Stuart, et al.
Science Translational Medicine|July 15, 2021
Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effectsMichelle Meyer, Bronwyn M Gunn, Delphine C Malherbe, et al.
Science (New York, N.Y.)|March 14, 2024
Oral administration of obeldesivir protects nonhuman primates against <i>Sudan ebolavirus</i>Robert W Cross, Courtney Woolsey, Victor C Chu, et al.
Emerging Infectious Diseases|March 21, 2007
Panmicrobial oligonucleotide array for diagnosis of infectious diseasesGustavo Palacios, Phenix-lan Quan, Omar J Jabado, et al.
The Lancet. Infectious Diseases|August 21, 2023
Revisiting the minimum incubation period of Zaire ebolavirusAaron D Kofman, Dana L Haberling, Gisele Mbuyi, et al.
Pathogens (Basel, Switzerland)|December 22, 2023
The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated MechanismsRobert W Cross, Christopher M Wiethoff, Patricia Brown-Augsburger, et al.
Cell|March 18, 2022
Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolavirusesJacob C Milligan, Carl W Davis, Xiaoying Yu, et al.
Pageof 28

Showing results (251-260 of 279) with videos related to

Sort By:
Pageof 28
Journal of Medicinal Chemistry|January 6, 2026
Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of HenipavirusesIrina N Gaisina, Malaika D Argade, Ryan Bott, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2016
Monoclonal antibody therapy for Junin virus infectionLarry Zeitlin, Joan B Geisbert, Daniel J Deer, et al.
Vaccines|October 27, 2022
Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical TrialsChristopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
The Journal of Infectious Diseases|July 20, 2023
Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal AntibodyDafna Abelson, Jennifer Barajas, Lauren Stuart, et al.
Science Translational Medicine|July 15, 2021
Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effectsMichelle Meyer, Bronwyn M Gunn, Delphine C Malherbe, et al.
Science (New York, N.Y.)|March 14, 2024
Oral administration of obeldesivir protects nonhuman primates against <i>Sudan ebolavirus</i>Robert W Cross, Courtney Woolsey, Victor C Chu, et al.
Emerging Infectious Diseases|March 21, 2007
Panmicrobial oligonucleotide array for diagnosis of infectious diseasesGustavo Palacios, Phenix-lan Quan, Omar J Jabado, et al.
The Lancet. Infectious Diseases|August 21, 2023
Revisiting the minimum incubation period of Zaire ebolavirusAaron D Kofman, Dana L Haberling, Gisele Mbuyi, et al.
Pathogens (Basel, Switzerland)|December 22, 2023
The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated MechanismsRobert W Cross, Christopher M Wiethoff, Patricia Brown-Augsburger, et al.
Cell|March 18, 2022
Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolavirusesJacob C Milligan, Carl W Davis, Xiaoying Yu, et al.
Pageof 28